Skip to main content
. 2020 Mar 12;35(Suppl 2):ii11–ii17. doi: 10.1093/ndt/gfaa020

Table 2.

Patient 2 treatment course for a 74-year-old female, 67 kg, with renal failure due to glomerulonephritis and with heart failure, pulmonary hypertension and hypotension

Date Echocardiographic data Dialysis and cardiac medication Symptoms
2014 EF 41%, PAP 60 with severe TR
  • ICHD 3×4h/week

  • ARB stopped; calcium channel antagonist stopped

  • Symptomatic hypotension

  • Not tolerating UF

2015 EF 60%, PAP 77, moderate– to–severe TR Frequent HHD, 6×2h with 20L Development of significant ascites, significant SOB
2016 EF 55–65%, PAP 21, mild TR Frequent HHD, 6×2h 45min, 25L, reintroduction of ARB Reduction in ascites, improvement in SOB
2019 EF 60–65%, normal PAP, trivial TR Frequent HHD, 6×2.5 h. ARB and calcium channel antagonist No ascites, no SOB, improved exercise tolerance

PAP, pulmonary artery pressure; TR, tricuspid regurgitation; SOB, shortness of breath.